The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

New Clinical trial to see of Cabo will trump Sutent. This is great.

sblairc
sblairc CSN Member Posts: 585 Member
in Kidney Cancer #1

Cabozanitinub is going to start studies to see if it will become a FIRST IN LINE drug for kidney cancer. 

This means that there could be a drug to come out ahead of the one already prescribed first, Sutent. 

I think the article says a Phase 3 trial is going to start of the drug.

http://www.fool.com/investing/2016/05/27/this-new-data-could-push-exelixis-cabometyx-over-1.aspx

 

This means we are getting another drug that will likely prolong survival. 

Like Care

Comments

  • Yeric
    Yeric CSN Member Posts: 65
    #2
    another drug

    I don't remember what drug I was getting that I was told  " There is'nt anything after this."  I do remember that it wasn't that long ago.  And here we are with new stuff to try faster than I can burn through what I am taking.  So, how many shares of drug company do I need to break even with treatment from said company??  Thanks for the link sblairc!!

    Bobby

    Like Care

Discussion Boards